Analyst stock forecast
Trevi Therapeutics Forecast: $28.18 Analyst Target
Direct answer
Trevi Therapeutics's average price target is $28.18.
The target implies +88.5% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +53.8%, the high target implies +167.6%, and the range spans 113.7% of the current price.
Forecast evidence checked September 21, 2026.
Get free Trevi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.95
- Average price target
- $28.18
- High price target
- $40.00
- Low price target
- $23.00
- Low target gap
- +53.8%
- Target upside
- +88.5%
- High target gap
- +167.6%
- Target range width
- 113.7%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- September 21, 2026
- Valid through
- September 28, 2026
Explore related company data
Read the frequently asked questions.
What is Trevi Therapeutics's average price target?
Trevi Therapeutics's verified average price target is $28.18. The target range is $23.00 to $40.00.
How far are Trevi Therapeutics's low and high targets from the recorded price?
The low target implies +53.8%, while the high target implies +167.6%.
How many analysts are included in Trevi Therapeutics's consensus?
The verified consensus includes 11 analysts.
How is Trevi Therapeutics's target upside or downside calculated?
The average target of $28.18 is divided by the recorded price of $14.95, then one is subtracted to produce +88.5%. This does not guarantee a future return.
When was Trevi Therapeutics's analyst forecast verified?
The data was verified on 2026-09-21. The dataset is valid through 2026-09-28.